Upstream Bio, Inc. UPB
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.98% | 44.69% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.98% | 44.69% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 15.98% | 44.69% | -- | -- | -- |
| SG&A Expenses | 16.73% | 38.64% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.30% | 80.59% | -- | -- | -- |
| Operating Income | -39.82% | -81.46% | -- | -- | -- |
| Income Before Tax | -49.80% | -97.98% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.80% | -97.98% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.80% | -97.98% | -- | -- | -- |
| EBIT | -39.82% | -81.46% | -- | -- | -- |
| EBITDA | -39.83% | -81.49% | -- | -- | -- |
| EPS Basic | 60.49% | 72.11% | -- | -- | -- |
| Normalized Basic EPS | 58.82% | 73.96% | -- | -- | -- |
| EPS Diluted | 60.49% | 72.11% | -- | -- | -- |
| Normalized Diluted EPS | 58.82% | 73.96% | -- | -- | -- |
| Average Basic Shares Outstanding | 38.95% | 105.15% | -- | -- | -- |
| Average Diluted Shares Outstanding | 38.95% | 105.15% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |